DSDamian Stencelewski

Damian Stencelewski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Damian Stencelewski has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Hepatic adenomatosis and steroid-induced liver tumors – a modern clinical challenge in gynecology and sports medicine

    by Damian Stencelewski, Łukasz Wójcik, Aleksandra Gorzynska-Schulz, Natalia Gorzynska, Michał Falis, Alicja Nierychlewska, Agata Bronisławska, Robert Bronisławski, Alicja Solecka, Lidia Kiełbratowska

    BackgroundHepatocellular adenoma (HCA) is a rare benign liver tumor strongly associated with hormonal exposure, particularly estrogen-containing oral contraceptives and anabolic-androgenic steroids. Although benign, HCA is clinically significant because of the risks of hemorrhage and malignant transformation into hepatocellular carcinoma (HCC), especially in high-risk molecular subtypes. AimThis narrative review summarizes current evidence on the molecular classification, pathogenesis, diagnosis, and management of hepatocellular adenoma and hepatic adenomatosis. Material and MethodsA literature review was conducted using the PubMed and Scopus databases. Studies on epidemiology, molecular mechanisms, diagnostic imaging, and therapeutic strategies were reviewed. ResultsHormonal exposure promotes hepatocellular proliferation through dysregulated estrogen and androgen signaling. β-catenin–activated adenomas carry the highest risk of malignant transformation, while inflammatory and HNF1A-inactivated subtypes show distinct molecular and imaging features. Hepatic adenomatosis is associated with an increased risk of complications. Magnetic resonance imaging is the diagnostic modality of choice, whereas biopsy is reserved for selected cases because of hemorrhagic risk. Management includes withdrawal of hormonal triggers and, when indicated, surgical resection or embolization. ConclusionsHCA is a molecularly heterogeneous, hormonally driven liver tumor requiring risk-adapted management. Early identification of high-risk lesions is essential to prevent hemorrhage and malignant transformation.

  • Open Access

    The Psychobiotics in Depression and Anxiety: Efficacy, Mechanisms, and the Underestimated Risk of Antibiotic Resistance

    by Alicja Solecka, Alicja Nierychlewska, Michał Falis, Robert Bronisławski, Agata Bronisławska, Damian Stencelewski, Laura Sikorska, Magdalena Boniecka, Michalina Grudzińska, Kamila Roman

    Background. Depression and anxiety are highly prevalent, and up to one-third of depressed patients fail to achieve remission despite standard pharmacotherapy. This gap has prompted interest in the gut microbiome, via the gut - brain axis, as an adjunctive target. Psychobiotics - probiotics, prebiotics, synbiotics, and postbiotics with documented mental health effects - are promising, though their microbiological safety remains underexplored. Aim. To synthesize evidence on psychobiotic efficacy in depression and anxiety, outline gut-brain mechanisms, and highlight safety concerns regarding antimicrobial resistance transfer from bacterial formulations. Material and methods. This narrative review was based on a literature search of PubMed and Google Scholar, identifying clinical trials, meta-analyses, and studies on gut-brain communication, microbiota composition in depression/anxiety, psychobiotic efficacy, and antibiotic resistance in probiotic strains. Results. Four gut-brain pathways were identified: vagal, HPA-axis, immune, and tryptophan/serotonin routes. Depression and anxiety are linked to dysbiosis with reduced butyrate-producing and increased pro-inflammatory taxa; causality is supported by fecal transplantation studies. Probiotics show the strongest evidence for antidepressant and anxiolytic effects, especially as pharmacotherapy adjuncts. Evidence for other forms remains limited. Many probiotic strains carry mobile antibiotic resistance genes, and their use during antibiotic therapy has been linked to expansion of the gut resistome, raising safety concerns. Conclusions. Probiotics offer the most robust evidence for adjunctive treatment; other forms need further research. Strain selection should weigh both efficacy and resistance safety.

  • Open Access

    The Tattoos and the risk of health complications: a narrative review

    by Alicja Nierychlewska, Michał Falis, Alicja Solecka, Agata Bronisławska, Robert Bronisławski, Damian Stencelewski, Laura Magdalena Sikorska, Magdalena Aleksandra Boniecka, Michalina Grudzińska

    Introduction: As tattooing has become a widespread form of body modification, concerns about its health safety have grown. Tattoo inks are mixtures of organic pigments and metal compounds whose toxicological profile after intradermal application remains incompletely understood. Aim: The aim of this review was to summarise the current knowledge on the health complications of tattooing, spanning dermatological, infectious, pigment-migration and oncological aspects. A second objective was to assess the quality of the available evidence. Material and method: A narrative review of English-language literature indexed in PubMed and Google Scholar up to December 2025 was performed, including original studies, reviews, case reports and regulatory documents. Results: Cutaneous complications are best documented - early inflammatory, infectious and allergic reactions, chronic allergy (mainly to red pigment), granulomatous and sarcoidal changes, photo-induced reactions and adverse effects of laser removal. Blood-borne transmission (HBV, HCV, HIV) is linked mainly to non-professional settings; HPV, HSV and rare infective endocarditis also occur. Pigment particles, metals and titanium dioxide may migrate to regional lymph nodes, with scarce data on systemic distribution. Lymphoma findings are divergent and skin cancers within tattoos appear incidental. Conclusions: Most complications are cutaneous and mild; serious systemic and oncological consequences are rare and not confirmed as direct effects. The main gaps concern ink toxicology and long-term pigment migration, justifying further research, improved regulation and high hygienic and diagnostic standards.

  • Open Access

    The Hyperandrogenism in Female Athletes: When Dermatological Signs Become an Endocrine and Sports Medicine Challenge

    by Damian Stencelewski, Jakub Pawlicki, Aleksandra Gorzynska-Schulz, Natalia Gorzynska, Michał Falis, Alicja Nierychlewska, Agata Bronisławska, Robert Bronisławski, Alicja Solecka, Lidia Kiełbratowska

    Background. Hyperandrogenism in female athletes represents a complex intersection of endocrinology, dermatology, and sports medicine, where visible dermatological markers often signal underlying endocrine dysfunction or exogenous exposure. Aim. This narrative review analyzes the pathophysiology, differential diagnosis, and clinical management of hyperandrogenism in female athletes, distinguishing between endogenous endocrine disorders, exercise-induced adaptations, and performance-enhancing drug use. Material and methods. A literature search of PubMed and Google Scholar was conducted to identify recent clinical guidelines, endocrinological studies, and sports medicine literature regarding female hyperandrogenism, dermatological manifestations, and RED-S. Results. Dermatological signs such as severe acne, hirsutism, and female pattern hair loss serve as critical clinical red flags. Differentiating pathological conditions like Polycystic Ovary Syndrome (PCOS) from Relative Energy Deficiency in Sport (RED-S) and exogenous androgen exposure is essential for accurate diagnosis and regulatory compliance in sports medicine. Conclusions. Effective management of hyperandrogenism in female athletes requires a multidisciplinary approach, combining dermatological evaluation, rigorous endocrine profiling, and sports medicine oversight to safeguard both athletic health and long-term well-being.